Mark L. Bagarazzi
- Immunology top 2%
- Molecular Biology
- Virology top 1%
- Epidemiology top 5%
- Infectious Diseases top 5%
- Co-authors
- David B. WeinerJean BoyerMichael A. ChattergoonRichard B. CiccarelliKenneth E. UgenRichard S. GinsbergRob Roy MacGregorVelpandi Ayyavoo
- Topics
- HIV Research and Treatment (21 papers)Immunotherapy and Immune Responses (15 papers)Immune Cell Function and Interaction (8 papers)
- Partner nations
- United StatesItalyCanada
In The Last Decade
Mark L. Bagarazzi
37 papers receiving 1.9k citations
Hit Papers
Peers
Comparison fields: 5 of 75
- Immunology 1.3k
- Molecular Biology 687
- Virology 621
- Epidemiology 585
- Infectious Diseases 428
Countries citing papers authored by Mark L. Bagarazzi
This map shows the geographic impact of Mark L. Bagarazzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark L. Bagarazzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark L. Bagarazzi more than expected).
Fields of papers citing papers by Mark L. Bagarazzi
This network shows the impact of papers produced by Mark L. Bagarazzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark L. Bagarazzi. The network helps show where Mark L. Bagarazzi may publish in the future.
Co-authorship network of co-authors of Mark L. Bagarazzi
This figure shows the co-authorship network connecting the top 25 collaborators of Mark L. Bagarazzi. A scholar is included among the top collaborators of Mark L. Bagarazzi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark L. Bagarazzi. Mark L. Bagarazzi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 34 | |
| 2 | 1 | |
| 3 | 7 | |
| 4 | 2 | |
| 5 | 14 | |
| 6 | 64 | |
| 7 | 229 | |
| 8 | 29 | |
| 9 | 55 | |
| 10 | 123 | |
| 11 | 26 | |
| 12 | 48 | |
| 13 | 71 | |
| 14 | 63 | |
| 15 | 17 | |
| 16 | First Human Trial of a DNA-Based Vaccine for Treatment of Human Immunodeficiency Virus Type 1 Infection: Safety and Host Responsebreakdown → | 503 |
| 17 | 40 | |
| 18 | 20 | |
| 19 | 32 | |
| 20 | 4 |
About Mark L. Bagarazzi
Mark L. Bagarazzi is a scholar working on Virology, Immunology and Otorhinolaryngology, having authored 38 papers that have together received 2.0k indexed citations. Recurring topics across this work include HIV Research and Treatment (21 papers), Immunotherapy and Immune Responses (15 papers) and Immune Cell Function and Interaction (8 papers). The work is most often cited by research in Virology (621 citations), Immunology (1.3k citations) and Infectious Diseases (428 citations). Mark L. Bagarazzi has collaborated with scholars based in United States, Italy and Canada. Frequent co-authors include David B. Weiner, Jean Boyer, Michael A. Chattergoon, Richard B. Ciccarelli, Kenneth E. Ugen, Richard S. Ginsberg, Rob Roy MacGregor, Velpandi Ayyavoo, Leslie R. Coney and Theresa Higgins. Their work appears in journals such as Journal of Clinical Oncology, Nature Biotechnology and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.